Home » Trials » SLCTR/2018/003

A study to assess the effectiveness of an educational intervention to improve the safety culture among pharmacists involved in the dispensing process


SLCTR Registration Number


Date of Registration

24 Jan 2018

The date of last modification

Jan 29, 2019

Application Summary

Scientific Title of Trial

A study to assess the effectiveness of an educational intervention to improve the safety culture among pharmacists involved in the dispensing process

Public Title of Trial

Measuring safety culture among pharmacists involved in dispensing

Disease or Health Condition(s) Studied

Medication safety

Scientific Acronym


Public Acronym


Brief title


Universal Trial Number


Any other number(s) assigned to the trial and issuing authority

64/17 (ERC: FMS, USJP)

Trial Details

What is the research question being addressed?

Can an educational workshop on medication safety improve the safety culture among pharmacists involved in dispensing medicines in the hospital?

Type of study


Study design


Single arm study


Masking not used






Health services research

Study Phase

Not Applicable

Intervention(s) planned

An educational intervention will be conducted among the study participants. The study will be conducted at the department of pharmacy of the study hospital. All pharmacists who fulfil the inclusion criteria will be included in the study. A single session (half a day), group basis, educational workshop will be conducted on ‘safety culture’ and patient safety for pharmacists. The workshop will be resourced by senior pharmacologists, pharmacists and medical administrators involved in patient safety. The workshop will consist of lectures and group work related to medication safety. After educational presentations by resource persons, participating pharmacists will be actively involved in planning and preparing an educational poster on safety culture during the work shop. The prepared poster will be for display in their respective pharmacies in the study hospital for repeated emphasis.

Inclusion criteria

  1. Pharmacists involved in the dispensing process in their daily routine of work.
  2. Pharmacists with at least one year of experience at 1st January 2018
  3. Pharmacists who are qualified with either “Proficiency in Pharmacy”, Diploma in Pharmacy (University of Colombo) or Degree in Pharmacy.

Exclusion criteria

Pharmacists not registered in the Sri Lanka Medical Council

Primary outcome(s)

  1. Safety culture measured by an interviewer administered questionnaire introduced by the Agency for Healthcare Research and Quality, USA and content validated to suit the Sri Lankan context.


    Before the intervention and one month after the completion of the intervention.


Secondary outcome(s)

  1. None




Target number/sample size

All dispensing pharmacists in the study hospital ( N = 20)

Countries of recruitment

Sri Lanka

Anticipated start date


Anticipated end date


Date of first enrollment

Date of study completion

Recruitment status


Funding source

University grants Ref No: ASP/01/RE/MED/2017/37, awarded by University of Sri Jayewardenepura

Regulatory approvals

State of Ethics Review Approval



Date of Approval


Approval number


Details of Ethics Review Committee

Name: Ethics Review Committee, Faculty of Medical Sciences, University of Sri Jayewardenepura
Institutional Address: Gangodawila, Nugegoda Sri Lanka
Telephone: +94-112758000 (Extension: 4075)
Email: erc.fms.usjp@gmail.com

Contact & Sponsor Information

Contact person for Scientific Queries/Principal Investigator

J. A. Lakshika Anjalee
Colombo South Teaching Hospital, Kalubowila.
0112763261ext 284


Contact Person for Public Queries

Dr. N.R. Samaranayake
Senior Lecturer
Department of Allied Health Sciences, Faculty of Medical Sciences, University of Sri Jayewardenepura.


Primary study sponsor/organization

University of Sri Jayewardenepura

Gangodawila, Nugegoda, Sri Lanka
Tel: +94 11 2758000,

Email: info@sjp.ac.lk

Secondary study sponsor (If any)


Trial Completion details

Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?

IPD sharing plan description

Not available

Study protocol available

Protocol version and date

Not Available

Protocol URL

Not Available

Results summary available


Date of posting results

Date of study completion

Final sample size

Date of first publication

Link to results

Brief summary of results